BioSpace News Archive

Newly ID’ed T-Cells Have Potential to Become Universal Cancer Therapy

The researchers essentially identified a new T-cell and its receptor that appears able to search out and kill a broad range of cancer cells, including lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells.

January 21, 2020
·
2 min read
·
Mark Terry
Business

As its Drug Business Sees Growth in 2019, Lonza Continues to Search for New CEO

Albert Baehny, chairman of the board of directors, said the company looks forward to the coming challenges of 2020, including the naming of a new CEO.

January 21, 2020
·
2 min read
·
Alex Keown
Drug Development

Is Alzheimer’s Type 3 Diabetes? Novo Nordisk is Willing to Find Out

Novo Nordisk specializes in the diabetes market. The company appears to be making an entry into the Alzheimer’s market, which isn’t as unusual or unexpected as it initially sounds.

January 21, 2020
·
3 min read
·
Mark Terry
Job Trends

After $12 Million in Incentives, Eli Lilly Adding 462 Jobs in North Carolina

The positions will be in manufacturing, assembly and packaging. The NC Department of Commerce approved the incentives this morning.

January 21, 2020
·
3 min read
·
Mark Terry
Deals

HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic

Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models

January 21, 2020
·
2 min read
Deals

4basebio AG decides to buy back 2 million treasury shares

Voluntary public share buyback offer against cash payment in a purchase price range of EUR 1.60 to EUR 1.85 per share

January 21, 2020
·
4 min read
Business

PhoreMost Will Use Screening Platform to Boost Otsuka’s Gene Therapy Program

PhoreMost and Otsuka Pharmaceutical Co. entered into a multi-project collaboration to seek out disease-relevant pathways that can be exploited for the development of gene therapies to treat different illnesses.

January 21, 2020
·
2 min read
·
Alex Keown
Genetown

Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells

Scientists at the Broad Institute of MIT and Harvard tested about 4,518 drugs on 578 human cancer cell lines. They discovered that almost 50 had previously unrecognized anti-cancer properties.

January 21, 2020
·
3 min read
·
Mark Terry
Sensyne Health Study Shows Heart Failure Patients Benefit from Anticoagulants

A U.K. study confirmed that the use of blood-thinning medications benefits all heart failure patients, regardless of whether or not those patients have been diagnosed with atrial fibrillation.

January 21, 2020
·
2 min read
·
Alex Keown
Deals

Evotec SE: Increase of profitability guidance for financial year 2019

Evotec SE announced an increase in its profitability guidance for the financial year 2019 after the preliminary completion of the latest evaluation of the Company’s financial performance.

January 21, 2020
·
1 min read